BBIO Latest Headlines

BridgeBio gains amid report of settlement in Pfizer Vyndamax patent dispute

at seekingalpha.com (Fri, 24-Apr 1:58 PM)

BridgeBio Pharma (BBIO) Receives a Buy from Piper Sandler

at www.tipranks.com (Thu, 23-Apr 7:41 AM)

Wall Street Analysts Are Bullish on Top Healthcare Picks

at www.tipranks.com (Wed, 22-Apr 4:50 AM)

Piper Sandler Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

at www.tipranks.com (Mon, 20-Apr 7:18 AM)

BridgeBio Achieves Landmark Phase 3 Results With Infigratinib—First Statistically Significant Gains in Body Proportionality for Achondroplasia

Market Chameleon (Thu, 12-Feb 11:12 AM)

BridgeBio’s Oral Infigratinib Achieves First Statistically Significant Improvements in Body Proportionality for Achondroplasia in Phase 3 Trial

Market Chameleon (Thu, 12-Feb 7:58 AM)